Sign in

CIK 0000812796

  • Non-accelerated filer
  • Smaller reporting company

SOLIGENIX, INC.

Sign in to watch
Ticker
SNGX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
411505029
Phone
+1 609-538-8200
Business address
29 EMMONS DRIVE, SUITE B-10, PRINCETON, NJ, 08540
Former names
SOLIGENIX, INC., DOR BIOPHARMA INC, ENDOREX CORP, IMMUNOTHERAPEUTICS INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Open-market buy SENIOR VICE PRESIDENT AND CMO bought 8,000 shares at $0.50 ($4,000)
  8. 4 Open-market buy CHAIRMAN, CEO AND PRESIDENT bought 20,000 shares at $0.44 ($8,866)
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Open-market buy CHAIRMAN, CEO AND PRESIDENT bought 7,000 shares at $0.74 ($5,179)
  13. 4 Open-market buy Senior Vice President and CFO bought 1,000 shares at $0.70 ($700)
  14. 4 Open-market buy Senior Vice President and CFO bought 10,000 shares at $0.71 ($7,119)
  15. 4 Open-market buy Chairman, CEO and President bought 10,000 shares at $0.73 ($7,269)
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 3 of 18 · 344 filings